AZD7594 + Placebo to match

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Safety

Conditions

Safety, Pharmacokinetics, Pharmacodynamics of AZD7594

Trial Timeline

Sep 1, 2012 โ†’ Jun 1, 2013

About AZD7594 + Placebo to match

AZD7594 + Placebo to match is a phase 1 stage product being developed by AstraZeneca for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT01636024. Target conditions include Safety, Pharmacokinetics, Pharmacodynamics of AZD7594.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01636024Phase 1Completed